Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EleZeggini
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EleZeggini
-
Eleftheria Zeggini proslijedio/la je Tweet
A multi-omics approach to construct molQTL map of cell types directly involved in osteoarthritis. Finds likely effector genes for osteoarthritis-associated genetic signals.
@SteinbergJulia@EleZeggini@futurenat@biorxivpreprinthttps://hubs.ly/H0mRN1C0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
We will miss you, dear friends in the UK!pic.twitter.com/mCzSGqyhy1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
To all our British friends and collaborators: This is not a goodbye, this is a thank you and a promise for new opportunities to work together for a healthier society.
#brexitpic.twitter.com/WGj2k1AF38
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Standing room only for
@ntziachristos talk on bioengineering in Munich tonight:)@MunichImagingpic.twitter.com/9uqvd4afXq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Delighted that the sequence-based copy number variant caller of our first-year PhD student Grace Png and Head of Analytics
@ArthurGilly made the cover of Genetic Epidemiology@genepisociety@HelmholtzMunich https://tinyurl.com/uk738aw :)pic.twitter.com/tSWoyigPri
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
Researchers are proud of what they do
But today’s #ResearchCulture is putting this at risk. Read our report and help#ReimagineResearch
https://wellc.me/2tfLahq pic.twitter.com/CWyvZVYqDUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
The 2nd round of calls for a multi-million-dollar research programme led & implemented by African scientists, working collaboratively to address challenges faced by people in African nations is now open.Apply before 28 Feb 2020
#DELTASAfrica Details
http://bit.ly/2ZgenV6 pic.twitter.com/an59LZ3vR9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
There is still time to become a member of
#ICDAbio! Sign up to receive ICDA updates: http://icda.bio/membership-signup …pic.twitter.com/GPGo5809y5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
Really interesting work highlighting the importance of integrating multiple omics to assist patient stratification and identify potential drug targets for a polygenic traithttps://www.biorxiv.org/content/10.1101/835850v1 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
Abstract submission for the 2020 Annual Meeting of the International Genetic Epidemiology Society in Seoul is now open! Abstracts due February 3. Note accelerated timeline: meeting is July 1-3 (not October, as is more usual).
@genepisociety https://iges.memberclicks.net/2020-abstractsPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
We are recruiting: *Director of Big Data Institute at University of Oxford.* There are few greater opportunities to lead a major centre at the intersection of data science and medical research.
@bdi_oxford@Oxford_NDPH@NDMOxford@OxfordBRC@hdruk https://my.corehr.com/pls/uoxrecruit/erq_jobspec_version_4.display_form?p_company=10&p_internal_external=E&p_display_in_irish=N&p_process_type=&p_applicant_no=&p_form_profile_detail=&p_display_apply_ind=Y&p_refresh_search=Y&p_recruitment_id=144348 …pic.twitter.com/g7SqYmgXj3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Juliane Winkelmann on the genetics of restless leg syndrome @ Digital Health Summit in Munich todaypic.twitter.com/bw4PVQkoR4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great talk on AI in biomedicine by
@fabian_theis at the Digital Health Summit in Munich todaypic.twitter.com/u93FrMEfcn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A first deep whole genome sequence-based look at 257 circulating protein biomarkers: novel common and rare variant pQTLs, polygenic risk score prediction and causal links to disease. All in a day’s work for
@ArthurGilly :)https://twitter.com/clintomics/status/1199810047058022400 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
So proud of this work and its potential to accelerate translation for a disease of huge public health burden: https://tinyurl.com/srpa29h
@SteinbergJuliaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
Great Review issue from
@hmg_journal, including -@minouye271's#polygenic risk score review paper -@cecilejanssens on validity of PRS - and many other gems. https://academic.oup.com/hmg/issue/28/R2Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Eleftheria Zeggini proslijedio/la je Tweet
@HelmholtzMunich program evaluation finally done
now we just need someone to help us with our alcoholic fatty liver disease tomorrow
@EleZeggini@ntziachristos@epigeneticsHMGUpic.twitter.com/DFCM4yGRCp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
Now open: our 2019 call for @helmholtz_ai Projects!
Apply for collaborative #ML#AI high-risk high-gain projects with a duration of max. 3 years.
Find all information and the submission portal on our website http://bit.ly/34Mly9c pic.twitter.com/h2J2L1jBz1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eleftheria Zeggini proslijedio/la je Tweet
Now panel discussion lead by Adam Smith with Nicola Bedlington,
@MichelGoldman, Thomas Lindahl and@EleZeggini on the future of drug development and precision medecine.#NobelPrizeDialogue#BerlinSciWeek19pic.twitter.com/deEceyj2Mk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.